Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTonLVT
NCT05892042Recruiting
- Sponsor
- Jilin University
- Start
- May 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rivaroxaban in left ventricular thrombus (LVT) (2 arms), sponsored by Jilin University. Primary endpoint: Percentage of participants with the first occurrence of Stroke and other systemic embolism at 12 months. Started May 2023; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT05892042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05892042.